Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Asset Utilization Ratio (2019 - 2025)

10x Genomics (TXG) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.62 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 5.56% to 0.62 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.62 through Dec 2025, down 5.56% year-over-year, with the annual reading at 0.66 for FY2025, 1.15% up from the prior year.
  • Asset Utilization Ratio hit 0.62 in Q4 2025 for 10x Genomics, down from 0.64 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.69 in Q1 2025 to a low of 0.35 in Q1 2021.
  • Historically, Asset Utilization Ratio has averaged 0.57 across 5 years, with a median of 0.59 in 2023.
  • Biggest YoY gain for Asset Utilization Ratio was 61.06% in 2021; the steepest drop was 18.67% in 2021.
  • Year by year, Asset Utilization Ratio stood at 0.49 in 2021, then grew by 4.46% to 0.51 in 2022, then increased by 26.79% to 0.65 in 2023, then rose by 1.76% to 0.66 in 2024, then decreased by 5.56% to 0.62 in 2025.
  • Business Quant data shows Asset Utilization Ratio for TXG at 0.62 in Q4 2025, 0.64 in Q3 2025, and 0.68 in Q2 2025.